Concepedia

Yasunori Hase

YH

Statistics

Publications

14

Citations

659

H-Index

14

Active since

1998

Affiliations

Japan Tobacco (Japan)(Current)

Orphagen Pharmaceuticals (United States)

Yasunori Hase is an author at Japan Tobacco (Japan) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1998–2020

14

Publications

14

Catalytic Asymmetric Aminolysis of 3,5,8-Trioxabicyclo[5.1.0]octane Providing an Optically Pure 2-Amino-1,3,4-butanetriol Equivalent

Shoichi Sagawa, Hiroyuki Abé, Yasunori Hase et al. · The Journal of Organic Chemistry · 1999 · 139 citations

, , +6

Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors

Kazutaka Ikegashira, Takahiro Oka, Shintaro Hirashima et al. · Journal of Medicinal Chemistry · 2006 · 112 citations · Full text

, , +17

SAR Exploration Guided by LE and Fsp <sup>3</sup> : Discovery of a Selective and Orally Efficacious RORγ Inhibitor

Kazuyuki Hirata, Masayuki Kotoku, Noriyoshi Seki et al. · ACS Medicinal Chemistry Letters · 2015 · 59 citations · Full text

, , +16

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders

Satoru Noji, Yoshinori Hara, Tomoya Miura et al. · Journal of Medicinal Chemistry · 2020 · 56 citations · Full text

, , +17

Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia

Yosuke Ogoshi, Takuya Matsui, Ikuo MITANI et al. · ACS Medicinal Chemistry Letters · 2017 · 52 citations · Full text

, , +13

1–5 of 14